scPharmaceuticals Inc
NASDAQ:SCPH
Earnings Announcements
scPharmaceuticals Inc Reports Fourth Quarter And Full Year 2021 Financial Results
Published: 03/22/2022 11:41 GMT
scPharmaceuticals Inc (SCPH) - Scpharmaceuticals Inc. Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Business Update.
Scpharmaceuticals Inc - Ended Q4 With Cash, Cash Equivalents, Restricted Cash and Investments of $75.5 Million.
Scpharmaceuticals Inc - Qtrly Loss per Share $0.27.
Scpharmaceuticals Inc - Ended Q4 With Cash, Cash Equivalents, Restricted Cash and Investments of $75.5 Million.
Scpharmaceuticals Inc - Qtrly Loss per Share $0.27.
Revenue is expected to be $0 Million
Adjusted EPS is expected to be -$0.33
Next Quarter Revenue Guidance is expected to be $0 Million
Next Quarter EPS Guidance is expected to be -$0.41
More details on our Analysts Page.
Adjusted EPS is expected to be -$0.33
Next Quarter Revenue Guidance is expected to be $0 Million
Next Quarter EPS Guidance is expected to be -$0.41
More details on our Analysts Page.